Abiopharma

Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management

Lillys sofetabart mipitecan receives U.S. FDAs Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer

New Form SC 13E3/A - LakeShore Biopharma Co., Ltd. Filed: 2026-01-20 AccNo: 0001213900-26-005369 Size: 1 MB

New Form SC14D9C - RAPT Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001193125-26-015978 Size: 90 KB

Pitteroff Valerie Christine 🟢 acquired 4.0K shares of CARDINAL HEALTH INC (CAH) at $213.26 Transaction Date: Jan 15, 2026 | Filing ID: 000004

Immuron Limited (IMRN) Files Form 6-K

(100% Positive) 908 Devices Inc (MASS) Reports Q1 2026 Financial Results

Novavax Announces Entering into a License Agreement with Pfizer

New Form SC14D9C - RAPT Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001193125-26-015962 Size: 21 KB

(90% Positive) Corvus Pharmaceuticals Inc (CRVS) Announces Enrollment Update for soquelitinib Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

CAN FITE BIO (CANF) Files Form 6-K

New Form 15-12G - Cidara Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001193125-26-015957 Size: 11 KB

NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing

Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Me...

Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson